BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24153206)

  • 1. Design, synthesis and in vitro anticancer evaluation of 4,6-diamino-1,3,5-triazine-2-carbohydrazides and -carboxamides.
    Kothayer H; Elshanawani AA; Abu Kull ME; El-Sabbagh OI; Shekhar MP; Brancale A; Jones AT; Westwell AD
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6886-9. PubMed ID: 24153206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
    Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel inhibitors of Rad6 ubiquitin conjugating enzyme: design, synthesis, identification, and functional characterization.
    Sanders MA; Brahemi G; Nangia-Makker P; Balan V; Morelli M; Kothayer H; Westwell AD; Shekhar MPV
    Mol Cancer Ther; 2013 Apr; 12(4):373-83. PubMed ID: 23339190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic approaches for sulfur derivatives containing 1,2,4-triazine moiety: their activity for in vitro screening towards two human cancer cell lines.
    Karczmarzyk Z; Wysocki W; Urbańczyk-Lipkowska Z; Kalicki P; Bielawska A; Bielawski K; Ławecka J
    Chem Pharm Bull (Tokyo); 2015; 63(7):531-7. PubMed ID: 26133068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
    Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
    Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of novel 1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]indole-3-carboxamide analogs in MCF-7 and MDA-MB-468 breast cancer cell lines.
    Kim YJ; Pyo JS; Jung YS; Kwak JH
    Bioorg Med Chem Lett; 2017 Feb; 27(3):607-611. PubMed ID: 27993518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,4-Triazine Sulfonamides: Synthesis by Sulfenamide Intermediates, In Vitro Anticancer Screening, Structural Characterization, and Molecular Docking Study.
    Branowska D; Karczmarzyk Z; Wolińska E; Wysocki W; Morawiak M; Urbańczyk-Lipkowska Z; Bielawska A; Bielawski K
    Molecules; 2020 May; 25(10):. PubMed ID: 32429377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity.
    Mojzych M; Bielawska A; Bielawski K; Ceruso M; Supuran CT
    Bioorg Med Chem; 2014 May; 22(9):2643-7. PubMed ID: 24713308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines.
    Mojzych M; Šubertová V; Bielawska A; Bielawski K; Bazgier V; Berka K; Gucký T; Fornal E; Kryštof V
    Eur J Med Chem; 2014 May; 78():217-24. PubMed ID: 24681986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
    H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and anti-breast cancer evaluation of new triarylethylene analogs bearing short alkyl- and polar amino-/amido-ethyl chains.
    Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1963-9. PubMed ID: 26972118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.
    Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F
    Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structure and anticancer activity of novel 2,4-diamino-1,3,5-triazine derivatives.
    Saczewski F; Bułakowska A; Bednarski P; Grunert R
    Eur J Med Chem; 2006 Feb; 41(2):219-25. PubMed ID: 16377034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of antitumoral activity of ester and amide derivatives of 2-arylamino-6-trifluoromethyl-3-pyridinecarboxylic acids.
    Onnis V; Cocco MT; Lilliu V; Congiu C
    Bioorg Med Chem; 2008 Mar; 16(5):2367-78. PubMed ID: 18065230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of substituted pyrido[3,2-d]-1,2,3-triazines as potential Pim-1 inhibitors.
    Fan YB; Li K; Huang M; Cao Y; Li Y; Jin SY; Liu WB; Wen JC; Liu D; Zhao LX
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1224-8. PubMed ID: 26804231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines.
    Onnis V; Cocco MT; Fadda R; Congiu C
    Bioorg Med Chem; 2009 Sep; 17(17):6158-65. PubMed ID: 19679483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Di- and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish embryos.
    El-Faham A; Farooq M; Almarhoon Z; Alhameed RA; Wadaan MAM; de la Torre BG; Albericio F
    Bioorg Chem; 2020 Jan; 94():103397. PubMed ID: 31706684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Biological Evaluation of Amidinourea and Triazine Congeners as Inhibitors of MDA-MB-231 Human Breast Cancer Cell Proliferation.
    Bass R; Jenkinson S; Wright J; Smulders-Srinivasan T; Marshall JC; Castagnolo D
    ChemMedChem; 2017 Feb; 12(4):288-291. PubMed ID: 28076663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
    Saczewski F; Bułakowska A
    Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinazoline based 1,3,5-triazine derivatives as cancer inhibitors by impeding the phosphorylated RET tyrosine kinase pathway: Design, synthesis, docking, and QSAR study.
    Pathak P; Naumovich V; Grishina M; Shukla PK; Verma A; Potemkin V
    Arch Pharm (Weinheim); 2019 Sep; 352(9):e1900053. PubMed ID: 31380598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.